What is BTIG's price target for DNA?

BTIG's latest stated price target for Ginkgo Bioworks Holdings Inc. (DNA) is $12, from its action on Jan 7, 2022.

What is BTIG's rating on DNA?

BTIG rates DNA Sell, a bearish rating, as of May 15, 2024.

When did BTIG last change its view on DNA?

On May 15, 2024, BTIG downgrades to Sell from Neutral.

BTIG DNA price target and rating history

Ginkgo Bioworks Holdings Inc. (DNA) · Health Care

BTIG rates Ginkgo Bioworks Holdings Inc. (DNA) Sell with a $12 price target, as of its latest action on May 15, 2024. It has published 3 rating actions on DNA since January 2022, including 0 upgrades and 2 downgrades.

Current rating: Sell
Price target: $12
Median target, all firms: Too few
Actions on DNA: 3

Every BTIG rating on DNA

May 15, 2024
DowngradeBTIG downgrades to Sell from Neutral
Nov 9, 2023
DowngradeBTIG downgrades to Neutral from Buy
Jan 7, 2022
InitiateBTIG starts coverage at Buy, price target $12

Questions about BTIG and DNA

What is BTIG's price target for DNA?: BTIG's latest stated price target for Ginkgo Bioworks Holdings Inc. (DNA) is $12, from its action on Jan 7, 2022.
What is BTIG's rating on DNA?: BTIG rates DNA Sell, a bearish rating, as of May 15, 2024.
When did BTIG last change its view on DNA?: On May 15, 2024, BTIG downgrades to Sell from Neutral.

More DNA rating histories

All BTIG ratings DNA news and filings Every analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.